ea0029p1566 | Thyroid (non-cancer) | ICEECE2012
Covelli D.
, Vannucchi G.
, Curro N.
, Campi I.
, Guastella C.
, Pignataro L.
, Peccoz P Beck
, Salvi M.
Dysthyroid optic neuropathy (DON) is a sight threatening complication occurring in 35% patients with Graves orbitopathy. The medical treatment consists in the infusion of high dose of methylprednisolone (MP), while surgical orbital decompression is mandatory in patients non responding to the medical treatment. We aimed at studying the response to high dose steroids in DON and parameters for predicting therapy effectiveness. Twenty-three patients with DON were studi...